Archives
-
SAG for Astrocyte Mitochondrial Rescue
2026-09-09
SAG is a Smoothened receptor agonist that enables controlled Hedgehog pathway activation in neural and developmental models. This article translates evidence from frataxin-deficient astrocytes into practical assay decisions, exposure controls, and cross-domain safety interpretation.
-
Reserpine (N1867): Practical Lab Workflow
2026-09-09
This guide provides practical handling, preparation, storage, and QC recommendations for Reserpine (SKU N1867) when no directly matched paper evidence is available. It is intended for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research, not for diagnostic, therapeutic, clinical, or veterinary use.
-
From CpAdhE to Natural Product Discovery
2026-09-08
A mechanism-aware strategy for using natural product screening to expand CpAdhE-centered antiparasitic research from validated imidazole activity toward broader chemical and cellular discovery.
-
Dasatinib (BMS-354825) Kinase Research Guide
2026-09-08
Dasatinib, also called BMS-354825, is a research-use Src family and Bcr-Abl kinase inhibitor for dissecting phosphorylation-dependent cancer signaling. This guide separates biochemical potency, cell-model findings, animal-model observations, formulation parameters, and the boundaries of translating those results across CML, prostate cancer, PDAC, and thymic tumor research.
-
Peroxynitrite, Ca2+ Flux, and Cardiac Necroptosis
2026-09-07
Liu et al. identify a peroxynitrite-driven pathway linking hyperhomocysteinemia to ER stress, IP3R-dependent Ca2+ transfer, mitochondrial injury, and necroptosis in cardiac microvascular endothelial cells during ischemia–reperfusion. The findings position pathological ER–mitochondrial calcium coupling as a mechanistically relevant target for studying microvascular injury and reperfusion-related cardiac dysfunction.
-
Firefly Luciferase mRNA: Workflow and Optimization
2026-09-07
Build sensitive mRNA delivery, translation, viability, and imaging assays with Cap1-capped, 5-moUTP modified mRNA. A sex-aware design strategy helps distinguish reporter expression from immune-response differences in preclinical mouse studies.
-
From GABRA1 Proteostasis to Surface Biology
2026-09-05
GABRA1 frameshift variants expose a central translational challenge: total receptor abundance does not necessarily reveal how much functional protein reaches the cell surface. This thought-leadership article explains how Sulfo-NHS-SS-Biotin can help separate surface delivery from intracellular retention, while outlining experimental controls, competitive advantages, and the limits of extending a biochemical labeling strategy into disease-mechanism research.
-
Fluo-4 AM Calcium Assay Kit for Mechanotransduction
2026-09-04
Use the Fluo-4 AM Calcium Assay Kit to convert scaffold-driven Ca2+ signaling into a practical readout for annulus fibrosus cell phenotyping. Its 488 nm excitation, staining enhancers, and no-wash format support both mechanobiology workflows and scalable GPCR screening.
-
Magneto-Piezoelectric Scaffolds for Infected Bone Repair
2026-09-04
This ACS Nano study develops a dual-responsive, 3D-printed scaffold that combines magnetic biofilm disruption with ultrasound-triggered metabolic activation of Icam1+ macrophages. The work links JAK2-STAT3-associated oxidative phosphorylation to pro-reparative immune signaling, offering a coordinated strategy for infection control and bone regeneration.
-
Serotonin Inhibition of HRP Protein Labelling
2026-09-03
Chan and colleagues identify serotonin as a previously unrecognized inhibitor of HRP-mediated proximity biotinylation, while dopamine produces little interference under the tested conditions. Their combination of cell-based assays and label-free quantitative proteomics shows that Dz-PEG can consume serotonin and restore labelling efficiency, providing an important control strategy for serotonergic neuroscience workflows.
-
Quaternization Converts Spleen to Lung mRNA Tropism
2026-09-03
Huang and colleagues show that N-quaternization of the lipid-like compound tB-UC18 converts DOPE nanoassemblies from spleen-biased to highly lung-selective mRNA delivery after intravenous administration. The study identifies a comparatively simple head-group engineering strategy for non-liver delivery, while also highlighting the need to validate organ distribution, cellular uptake, and expression independently in relevant models.
-
Amikacin disulfate: Reliable Assay Workflows
2026-09-02
This scenario-based guide explains how Amikacin disulfate (SKU B1658) can support controlled antibiotic mechanism, protein-interaction, and contamination-related assay workflows without being mistaken for a mammalian viability reagent. It covers solution handling, data interpretation, controls, and practical vendor-selection criteria for reproducible laboratory studies.
-
DiscoveryProbe Natural Product Library Plus for AdhE
2026-09-02
Discover how the DiscoveryProbe Natural Product Library Plus can extend CpAdhE-centered antiparasitic research beyond single-chemotype screening. This mechanism-aware workflow combines biochemical inhibition, cellular phenotyping, and rigorous artifact control for natural product screening for drug discovery.
-
BQCA and the Next Logic of M1 Translation
2026-09-01
A mechanistic and translational perspective on how Benzyl Quinolone Carboxylic Acid (BQCA) can help researchers study M1 receptor signaling, pathway bias, neuronal activity, and Alzheimer’s disease biology with greater experimental precision.
-
Arrb2–6-ketoLCA Axis in Liver IRI
2026-09-01
This 2026 study identifies hepatocyte Arrb2 as a regulator of hepatic ischemia–reperfusion injury, linking hepatocyte signaling to increased 6-ketoLCA and M2 macrophage polarization. Its combination of clinical samples, conditional mouse modeling, hypoxia–reoxygenation experiments, and metabolite profiling provides a mechanistic framework for studying hepatocyte–macrophage communication in transplantation-related liver injury.